microscopy

Four panels of different fluorescent markers depicting sphingomyelin in a human cell infected with chlamydia.
| 4 min read
Different colored lines ranging from red to blue indicate the trajectories of Fyn proteins within a neuron.
| 2 min read
Illustration of neuron cells in the process of firing with electrical impulses traveling along their axons
Available on Demand
A photograph of three glass blown structures. Each structure depicts a blue tumor being attacked by purple cytotoxic T cells in 3D.
| 7 min read
A microscope image of a heart muscle cell stained in yellow and magenta against a black background.
| 7 min read
Mitochondria can modify their morphologies to meet the cell's energy needs.
| 1 min read
Richard Frye, a neurologist at Phoenix Children’s Hospital, analyzed the morphology of mitochondria (red) in patient-derived fibroblasts to determine if there was a connection between autism symptoms, mitochondrial function, and mitochondrial morphology.
| 4 min read
Mitochondria are dynamic organelles that change their morphology in response to the energetic needs of the cell. But in some diseases such as autism spectrum disorder, mitochondria don't appropriately respond, and the resulting metabolic dysfunction contributes to symptom severity.
| 1 min read
Erica Ollman Saphire smiles wearing a lab coat seated next to a microscope with computers in the background.
| 5 min read
Page 1 of 1 - 9 Total Items
Subscribe to Newsletter

Subscribe to our eNewsletters

Stay connected with all of the latest from Drug Discovery News.

Subscribe

Sponsored

Reliable fluid biomarkers strategies for clinical neuroscience research

Reliable fluid biomarkers strategies for clinical neuroscience research

Explore how validated fluid biomarker assays advance clinical research for neurological diseases.
A group of blue capsules is scattered on a bright yellow surface, with one capsule opened to reveal white powder inside.

Understanding drug impurities: types, sources, and analytical strategies

Unseen and often unexpected, drug impurities can slip in at every drug development stage, making their detection and control essential.
Laboratorian with a white coat and blue gloves pipettes green liquid into a beaker with multicolored liquids in beakers and tubes in the blue-tinged, sterile laboratory background.

Discovering cutting-edge nitrosamine analysis in pharmaceuticals

New tools help researchers detect and manage harmful nitrosamine impurities in drugs such as monoclonal antibodies.
Drug Discovery News March 2025 Issue
Latest IssueVolume 21 • Issue 1 • March 2025

March 2025

March 2025 Issue

Explore this issue